Invention Grant
- Patent Title: Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof
-
Application No.: US16475389Application Date: 2018-01-05
-
Publication No.: US10765680B2Publication Date: 2020-09-08
- Inventor: Dale Porter , Ensar Halilovic , Maïa Chanrion , Ana Leticia Maragno , Olivier Geneste , Delphine Merino , James Whittle , François Vaillant , Jane Visvader , Geoffrey Lindeman , Guillaume Lessene , Elisabetta Marangoni
- Applicant: LES LABORATOIRES SERVIER , NOVARTIS AG
- Applicant Address: FR Suresnes CH Basel
- Assignee: LES LABORATORIES SERVIER,NOVARTIS AG
- Current Assignee: LES LABORATORIES SERVIER,NOVARTIS AG
- Current Assignee Address: FR Suresnes CH Basel
- Agency: Hueschen and Sage
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4a88cc78
- International Application: PCT/EP2018/050298 WO 20180105
- International Announcement: WO2018/127575 WO 20180712
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K9/00 ; A61K31/337 ; A61P35/00
Abstract:
A combination comprising a MCL-1 inhibitor and a taxane compound, and compositions and uses thereof.
Public/Granted literature
- US20190336505A1 COMBINATION OF A MCL-1 INHIBITOR AND A TAXANE COMPOUND, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF Public/Granted day:2019-11-07
Information query
IPC分类:
